Parkinson’s disease is a progressive neurodegenerative disorder that affects the dopamine producing nerve cells in the brain. Parkinson’s disease primarily causes tremors, muscle stiffness, improper motor movements, and gait and balance problems. Secondary symptoms of Parkinson’s disease include anxiety, depression, and dementia.
How Big is The Global Parkinson’s Disease Treatment Market?
The Parkinson’s Disease Treatment Market is expected to be around US$ 7.50 Billion by 2028 at a CAGR of 6% in the given forecast period.
The major driving factors of Parkinson’s Disease Treatment Market are as follows:
The major restraints factors of Parkinson’s Disease Treatment Market are as follows:
The Parkinson’s Disease Treatment Market has been segmented as below:
By Drug Class:
By Distribution Channel:
By Patient Care Setting:
By Regional Analysis:
The Parkinson’s Disease Treatment Market is segmented on the lines of its drug class, distribution channel, patient care setting and regional. Based on drug class it covers Levodopa/carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-inhibitors, Anticholinergics and Other Drugs. Based on distribution channel type it covers Hospital Pharmacies, Retailer Pharmacies and Online Pharmacies. Based on patient care setting it covers Hospitals and Clinics. The Parkinson’s Disease Treatment Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Parkinson’s Disease Treatment Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Parkinson’s Disease Treatment Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report scope:
The scope of the report includes a detailed study of Parkinson’s Disease Treatment Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report GSK, Merck, Novartis, Teva, Boehringer Ingelheim, Impax, Abbvie, Valeant Pharmaceuticals, Lundbeck, Sun Pharma, Wockhardt, Acadia and UCB. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Parkinson’s Disease Treatment Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Parkinson’s Disease Treatment Market.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Veterinary Surgical Instruments Market
1. Introduction
1.1 Key Findings
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Data
2.2 Market Size Estimation and Data Triangulation
2.3 Research Assumptions
3. Summary with Insights
4. Market Overview
4.1 Introduction
4.2 Drivers
4.3 Restraints
4.4 Industry Trends
4.5 Porter’s Five Forces Analysis
5. Parkinson’s Disease Treatment Market Analysis, By Drug Class
5.1 Levodopa/carbidopa
5.2 Dopamine Receptor Agonists
5.3 MAO-Inhibitors
5.4 COMT-inhibitors
5.5 Anticholinergics
5.6 Other Drugs
6. Parkinson’s Disease Treatment Market Analysis, By Distribution Channel
6.1 Hospital Pharmacies
6.2 Retailer Pharmacies
6.3 Online Pharmacies
7. Parkinson’s Disease Treatment Market Analysis, By Patient Care Setting
7.1 Hospitals
7.2 Clinics
8. Parkinson’s Disease Treatment Market Analysis, By Region
8.1 North America
8.2 Europe
8.3 Asia-Pacific
8.4 Rest of the World
9. Competitive Overview
9.1 Introduction
9.2 New Product Launches
9.3 Acquisitions
9.4 Agreements, Partnerships, And Collaborations
9.5 Expansions
10. Company Profiles
10.1 Wockhardt
10.2 Novartis
10.3 Teva
10.4 GSK
10.5 Merck
10.6 Boehringer Ingelheim
10.7 Sun Pharma
10.8 Valeant Pharmaceuticals
10.9 Lundbeck
10.10 UCB
10.11 Acadia
10.12 Impax
10.13 Abbvie
The Parkinson’s Disease Treatment Market has been segmented as below:
By Drug Class:
By Distribution Channel:
By Patient Care Setting:
By Regional Analysis:
